Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | PAM | P19021 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol Dibutanoate SCHEMBL104207 | 0.90 | DGKA (0.65) | DGKAALDH1A1PAMADRA2AADRA1A | |
| SCHEMBL15636150 | 0.87 | DGKA (0.62) | DGKAALDH1A1PAMADRA2AADRA1A | |
| SCHEMBL17629665 | 0.86 | ALDH1A1 (0.50) | DGKAALDH1A1PAML3MBTL1 | |
| Diethylene Glycol Dibutanoate SCHEMBL421383 | 0.83 | DGKA (0.58) | DGKAALDH1A1PAMADRA2AADRA1A | |
| SCHEMBL181440 | 0.83 | ALDH1A1 (0.59) | DGKAALDH1A1PAMADRA2AADRA1A | |
| SCHEMBL13465983 | 0.83 | DGKA (0.58) | DGKAALDH1A1PAMADRA2AADRA1A | |
| Triethylene Glycol Dibutanoate SCHEMBL4305344 | 0.83 | DGKA (0.58) | DGKAALDH1A1PAMADRA2AADRA1A | |
| Ethylene Glycol Dibutanoate SCHEMBL50505 | 0.83 | DGKA (0.58) | DGKAALDH1A1PAMADRA2AADRA1A | |
| SCHEMBL29601907 | 0.83 | DGKA (0.58) | DGKAALDH1A1PAMADRA2AADRA1A | |
| SCHEMBL125157 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6750371-B2 | USING NITROXYL OXIDATION CATALYST IN LIQUID PHASE | CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2004-06-15 | — | — | US | disclosed |
| US-20030073871-A1 | Process for the oxidation of alcohols to aldehydes and ketones in the presence of nitroxyl compounds as catalysts | WACKER CHEMIE AG (DE) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073871-A1 | Process for the oxidation of alcohols to aldehydes and ketones in the presence of nitroxyl compounds as catalysts | ADH1C, ADH1A, ADH5 | DGKA 2496/4885ALDH1A1 70/4885PAM 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.